Use of Danzhi Xiaoyao Powder in the Treatment of Diseases by Chief Physician Wang Defen: Case Examples

Ying Luo
{"title":"Use of Danzhi Xiaoyao Powder in the Treatment of Diseases by Chief Physician Wang Defen: Case Examples","authors":"Ying Luo","doi":"10.26689/jcnr.v6i5.4282","DOIUrl":null,"url":null,"abstract":"Danzhi Xiaoyao powder was first introduced by Xue Ji, a Ming Dynasty physician, in the “Summary of Internal Medicine.” It is primarily used for treating the syndrome of liver depression transforming into heat and is widely used in the treatment of dermatology, internal medicine, gynecology, and other multi-system diseases. This medical prescription is aptly dispensed, its detoxification effect is strong, and it is a representative medical prescription for soothing the liver, strengthening the spleen and stomach, as well as eliminating heat stagnation. Chief Physician Wang Defen inherited the academic experience of the fifth batch of nationally known Chinese medicine experts, under the guidance of Professor Ji Haiwang, a notable Chinese medicine practitioner in Shaanxi Province and Professor Shi Bingyin, a renowned endocrinologist. Through follow-up studies, the various methods and empirical prescriptions of Danzhi Xiaoyao powder applied by Chief Physician Wang Defen in the treatment of common clinical diseases are summarized. They have been proven to have conclusive efficacy, thus providing guidance and reference for the dialectical treatment using traditional Chinese medicine.","PeriodicalId":64151,"journal":{"name":"临床护理研究","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"临床护理研究","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.26689/jcnr.v6i5.4282","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Danzhi Xiaoyao powder was first introduced by Xue Ji, a Ming Dynasty physician, in the “Summary of Internal Medicine.” It is primarily used for treating the syndrome of liver depression transforming into heat and is widely used in the treatment of dermatology, internal medicine, gynecology, and other multi-system diseases. This medical prescription is aptly dispensed, its detoxification effect is strong, and it is a representative medical prescription for soothing the liver, strengthening the spleen and stomach, as well as eliminating heat stagnation. Chief Physician Wang Defen inherited the academic experience of the fifth batch of nationally known Chinese medicine experts, under the guidance of Professor Ji Haiwang, a notable Chinese medicine practitioner in Shaanxi Province and Professor Shi Bingyin, a renowned endocrinologist. Through follow-up studies, the various methods and empirical prescriptions of Danzhi Xiaoyao powder applied by Chief Physician Wang Defen in the treatment of common clinical diseases are summarized. They have been proven to have conclusive efficacy, thus providing guidance and reference for the dialectical treatment using traditional Chinese medicine.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
王德芬主任医师应用丹脂逍遥散治疗疾病例
丹脂逍遥散最早由明代医生薛济在《内科要略》中介绍,主要用于治疗肝郁化热证,广泛用于皮肤科、内科、妇科等多系统疾病的治疗。此方配法适宜,解毒作用强,是疏肝、健脾、胃、消热滞的代表方。王德芬主任医师继承了第五批全国知名中医专家的学术经验,师从陕西省著名中医师纪海旺教授和著名内分泌学家史炳银教授。通过随访研究,总结了王德芬主任医师丹芝逍遥散治疗临床常见病的各种方法和经验方。它们已被证明具有决定性的疗效,从而为中医辨证治疗提供了指导和参考。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
236
期刊最新文献
The Effect of the Early Application of Tirofiban on Acute Ischemic Stroke (AIS) after Intravenous Thrombolysis with Urokinase Analysis of the Effect of Hormone Therapy Combined with Hydroxychloroquine in the Treatment of IgA Nephropathy Statistical Analysis and Countermeasures for Specimen Rejection in the Emergency Department Exploring the Mechanism of Circ-vgll3 in Osteogenically Differentiated Human Bone Marrow Mesenchymal Stem Cells Predictive Value of Serum pgRNA on HBeAg Clearance in Patients with Chronic Hepatitis B with Low HBeAg Levels Treated with Pegylated Interferon
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1